Network Pharmacology and Experimental Assessment to Explore the Pharmacological Mechanism of Qimai Feiluoping Decoction Against Pulmonary Fibrosis

Network Pharmacology and Experimental Assessment to Explore the Pharmacological Mechanism of Qimai Feiluoping Decoction Against Pulmonary Fibrosis

Pulmonary fibrosis (PF) is one of the pathologic changes in COVID-19 patients in convalescence, and it is also a potential long-term sequela in severe COVID-19 patients. Qimai Feiluoping decoction (QM) is a traditional Chinese medicine formula recommended in the Chinese national medical program for...

Full description

Saved in:
Bibliographic Details
Main Authors: Yingying Yang, Lu Ding, Tingting Bao, Yaxin Li, Jing Ma, Qingwei Li, Zezheng Gao, Siyu Song, Jing Wang, Jiachao Zhao, Ziyuan Wang, Daqing Zhao, Xiangyan Li, Zeyu Wang, Linhua Zhao, Xiaolin Tong
Format: article
Language:EN
Published: Frontiers Media S.A. 2021
Subjects:
COVID-19
pulmonary fibrosis
QM formula
network pharmacology
epithelial–mesenchymal transition
extracellular matrix accumulation
Therapeutics. Pharmacology
RM1-950
Online Access:https://doaj.org/article/37038ecd3f8e48de9b064789cccb8ed2
Tags: Add Tag
No Tags, Be the first to tag this record!
Be the first to leave a comment!
You must be logged in first

Similar Items